The association between anxiety and esophageal cancer: A nationwide population-based study

被引:6
作者
Zhu, Juan [1 ]
Zhou, Yueyue [2 ]
Ma, Shanrui [1 ]
Chen, Ru [1 ]
Xie, Shuanghua [1 ]
Liu, Zhengkui [2 ]
Li, Xinqing [1 ]
Wei, Wenqiang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, CAMS & PUMC, Natl Clin Res Ctr Canc, Canc Registry Off,Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[2] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China
关键词
endoscopy; esophageal cancer; GAD; gastroscopy; generalized anxiety disorder; health‐ related quality of life; high‐ risk regions; screening; TERM-FOLLOW-UP; MENTAL-DISORDERS; CHINA; DEPRESSION; PREVALENCE; MORTALITY; PEOPLE; RISK; METAANALYSIS; VALIDATION;
D O I
10.1002/pon.5580
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Research on generalized anxiety disorder (GAD) and its association with esophageal cancer (EC) is sparse. The study aimed to explore the association between GAD and EC. Methods A multicenter, population-based study in high-risk regions for EC (ECHRRs) was conducted from 2017 to 2019. All participants received free endoscopy screening. If the esophageal endoscopy results were suspicious, the pathological biopsy was performed to confirm normal, esophagitis, low-grade intraepithelial neoplasia (LGIN), high-grade intraepithelial neoplasia (HGIN), and EC. Information on participants' exposure to risk factors was collected. GAD was assessed with Generalized Anxiety Disorder Scale-7. Results With esophageal endoscopy, 25,650 participants in ECHRRs were examined, 9586 of whom were suspicious and confirmed by esophageal pathology. The detection rate of EC and precancerous lesions was 6.83% (1751/25,650), with 1377 LGIN (5.37%), 272 HGIN (1.06%), and 102 EC (0.40%) cases. The overall mean GAD score (95% CI) and prevalence among 25,650 participants with endoscopy were 1.96 (1.93-1.99) and 16.90%, respectively. The mean GAD score and prevalence among 9586 participants with pathology were 1.96 (1.91-2.02) and 17.98%, respectively. The mean GAD scores of patients confirmed with normal, esophagitis, LGIN, HGIN, and EC were 1.73 (1.62-1.85), 1.91 (1.85-1.97), 1.94 (1.80-2.08), 3.98 (3.73-4.23). and 2.97 (2.49-3.45), respectively (p < 0.001). The corresponding prevalence of GAD were 5.21%, 18.72%, 17.72%, 43.75%, and 36.27%, respectively (p < 0.001). The age- and gender-adjusted odds ratios (ORs) between GAD and each esophageal lesion type were 1.02 (0.99-1.04), 1.01 (0.98-1.04), 1.27 (1.21-1.33), and 1.16 (1.08-1.24), respectively. The ORs (95% CIs) of the positive associations were 1.08 (1.05-1.12), 1.03 (0.99-1.07), 1.35 (1.29-1.42), and 1.19 (1.10-1.29) after further adjustment for potential confounders (all p < 0.001). Sensitivity analysis showed that the positive association persisted. Conclusions GAD was significantly higher in patients with EC and precancerous lesions. Focusing on and alleviating anxiety in high-risk groups (including patients with HGIN and EC) may be an effective strategy for EC prevention and control. Further prospective studies are warranted to validate the results.
引用
收藏
页码:321 / 330
页数:10
相关论文
共 50 条
  • [21] The association between scabies and myasthenia gravis: A nationwide population-based cohort study
    Hsu, Ren-Jun
    Lin, Chien-Yu
    Chang, Fung-Wei
    Huang, Chun-Fa
    Chuang, Heng-Chang
    Liu, Jui-Ming
    JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 45 : 115 - 120
  • [22] Association between depression and enterovirus infection A nationwide population-based cohort study
    Liao, Yin-To
    Hsieh, Ming-Hong
    Yang, Yao-Hsu
    Wang, Ying-Ching
    Tsai, Ching-Shu
    Chen, Vincent Chin-Hung
    Gossop, Michael
    MEDICINE, 2017, 96 (05)
  • [23] Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study
    Um, Yoo Hyun
    Kim, Tae-Won
    Jeong, Jong-Hyun
    Hong, Seung-Chul
    Seo, Ho-Jun
    Han, Kyung-Do
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [24] The association between glaucoma and risk of depression: a nationwide population-based cohort study
    Chen, Yu-Yen
    Lai, Yun-Ju
    Wang, Jen-Pang
    Shen, Ying-Cheng
    Wang, Chun-Yuan
    Chen, Hsin-Hua
    Hu, Hsiao-Yun
    Chou, Pesus
    BMC OPHTHALMOLOGY, 2018, 18
  • [25] Association between psychiatric disorders and osteoarthritis: a nationwide longitudinal population-based study
    Huang, Shih-Wei
    Wang, Wei-Te
    Lin, Li-Fong
    Liao, Chun-De
    Liou, Tsan-Hon
    Lin, Hui-Wen
    MEDICINE, 2016, 95 (26)
  • [26] Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study
    Shen, Chih-Hao
    Chou, Chung-Hsing
    Liu, Feng-Cheng
    Lin, Te-Yu
    Huang, Wen-Yen
    Wang, Yu-Chiao
    Kao, Chia-Hung
    MEDICINE, 2016, 95 (08)
  • [27] Association between height and hypercholesterolemia in adults: a nationwide population-based study in Korea
    Lee, Mi Yeon
    Nam, Ga Eun
    Han, Kyungdo
    Kim, Da Hye
    Kim, Yang Hyun
    Cho, Kyung Hwan
    Park, Yong Gyu
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (01)
  • [28] Association between the Persistence of Obesity and the Risk of Gastric Cancer: A Nationwide Population-Based Study
    Lim, Joo Hyun
    Shin, Cheol Min
    Han, Kyung-Do
    Lee, Seung Woo
    Jin, Eun Hyo
    Choi, Yoon Jin
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    CANCER RESEARCH AND TREATMENT, 2022, 54 (01): : 199 - 207
  • [29] The association between prostate cancer and mood disorders: a nationwide population-based study in Taiwan
    Chen, Pan-Ming
    Chen, San-Chi
    Liu, Chia-Jen
    Hung, Man-Hsin
    Tsai, Chia-Fen
    Hu, Yu-Wen
    Chen, Mu-Hong
    Shen, Cheng-Che
    Su, Tung-Ping
    Yeh, Chiu-Mei
    Lu, Ti
    Chen, Tzeng-Ji
    Hu, Li-Yu
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (03) : 481 - 490
  • [30] Long-term anxiety and depression signatures of participants that received esophageal cancer screening: A multicenter population-based cohort study
    Zhu, Juan
    Ma, Shanrui
    Chen, Ru
    Xie, Shuanghua
    Liu, Zhaorui
    Liu, Zhengkui
    Wei, Wenqiang
    CANCER MEDICINE, 2023, 12 (05): : 6294 - 6306